Big Pharma Could Lift The SPDR Healthcare ETF in 2020

The SPDR Health Care ETF (XLV), one of the dominant names among healthcare ETFs, has been making its way higher in the fourth quarter after scuffling for much of 2019 and some market observers believe the good times can continue in 2020 as blue-chip pharmaceuticals stocks lead the way. Healthcare...